The United States has officially removed Venezuela from its list of nations failing to meet international counternarcotics commitments, marking a significant shift in its drug policy in the region. This decision stems from perceived progress in Venezuela’s efforts to combat drug-trafficking organizations under interim President Delcy Rodríguez.
Venezuela had previously been criticized by Washington for its inadequate counternarcotics initiatives, but recent actions appear to have altered this perception. The U.S. administration, led by President Donald Trump, noted these developments as a reason for the change in Venezuela’s status. Meanwhile, Colombia remains on the list, although President Trump hinted that it could be removed next year if further progress is demonstrated.
The White House currently lists Colombia among four countries that have not made substantial efforts in the past year to meet international counternarcotics obligations. Despite this, Trump acknowledged that Colombia could see its designation lifted if its government enhances efforts against coca cultivation, cocaine production, and the networks facilitating drug trafficking.
Colombian officials have expressed their commitment to addressing the entirety of the drug-trafficking chain. Their strategy includes targeting illicit crops, production facilities, trafficking routes, and the financial frameworks that support these activities. This comprehensive approach is aimed at fulfilling international demands for more robust counternarcotics measures.
The decisions regarding Venezuela and Colombia underscore Washington’s ongoing focus on strengthening counternarcotics cooperation throughout Latin America. Both countries remain categorized by the U.S. as major drug-transit or illicit drug-producing nations for the fiscal year 2027, although Venezuela’s exclusion from the list of non-compliant countries is a notable development.
